This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of biologically active molecules. It serves as a key intermediate in the creation of compounds that target neurological and psychiatric disorders, such as depression and anxiety, due to its structural similarity to pyridine derivatives known for their interaction with neurotransmitter receptors. Additionally, it is employed in the preparation of ligands for studying receptor binding affinity and selectivity, aiding in the design of new therapeutic agents. Its dihydrochloride form enhances solubility, making it suitable for use in aqueous-based experimental setups.